Syneos Health, Inc. - (SYNH): Price and Financial Metrics
GET POWR RATINGS... FREE!
SYNH POWR Grades
- SYNH scores best on the Value dimension, with a Value rank ahead of 91.56% of US stocks.
- SYNH's strongest trending metric is Growth; it's been moving down over the last 177 days.
- SYNH's current lowest rank is in the Momentum metric (where it is better than 19.86% of US stocks).
SYNH Stock Summary
- SYNH's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 2,068.44 -- higher than 98.4% of US-listed equities with positive expected earnings growth.
- In terms of volatility of its share price, SYNH is more volatile than 86.24% of stocks we're observing.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for SYNH comes in at 8.57% -- higher than that of 80.68% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to SYNEOS HEALTH INC, a group of peers worth examining would be FHB, HFBL, EFX, PB, and BERY.
- Visit SYNH's SEC page to see the company's official filings. To visit the company's web site, go to www.syneoshealth.com.
SYNH Valuation Summary
- SYNH's EV/EBIT ratio is 16; this is 142.42% higher than that of the median Healthcare stock.
- SYNH's price/sales ratio has moved down 0.5 over the prior 102 months.
Below are key valuation metrics over time for SYNH.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
SYNH | 2023-03-24 | 0.7 | 1 | 13.4 | 16.0 |
SYNH | 2023-03-23 | 0.6 | 1 | 12.9 | 15.7 |
SYNH | 2023-03-22 | 0.6 | 1 | 13.1 | 15.8 |
SYNH | 2023-03-21 | 0.7 | 1 | 13.6 | 16.1 |
SYNH | 2023-03-20 | 0.7 | 1 | 13.2 | 15.9 |
SYNH | 2023-03-17 | 0.6 | 1 | 12.9 | 15.7 |
SYNH Growth Metrics
- Its 2 year revenue growth rate is now at 13.14%.
- Its 5 year net income to common stockholders growth rate is now at 67.37%.
- Its year over year net income to common stockholders growth rate is now at 22.4%.

The table below shows SYNH's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 5,393.082 | 426.981 | 266.497 |
2022-09-30 | 5,406.599 | 489.143 | 286.928 |
2022-06-30 | 5,418.606 | 405.272 | 278.122 |
2022-03-31 | 5,340.478 | 394.077 | 242.283 |
2021-12-31 | 5,212.97 | 450.278 | 234.831 |
2021-09-30 | 4,979.605 | 378.625 | 250.758 |
SYNH's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- SYNH has a Quality Grade of D, ranking ahead of 21.57% of graded US stocks.
- SYNH's asset turnover comes in at 0.618 -- ranking 262nd of 563 Business Services stocks.
- INS, HURN, and MEDP are the stocks whose asset turnover ratios are most correlated with SYNH.
The table below shows SYNH's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.618 | 0.233 | 0.100 |
2021-06-30 | 0.602 | 0.238 | 0.096 |
2021-03-31 | 0.579 | 0.234 | 0.085 |
2020-12-31 | 0.580 | 0.230 | 0.083 |
2020-09-30 | 0.602 | 0.225 | 0.067 |
2020-06-30 | 0.612 | 0.218 | 0.070 |
SYNH Price Target
For more insight on analysts targets of SYNH, see our SYNH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $80.92 | Average Broker Recommendation | 1.33 (Strong Buy) |
SYNH Stock Price Chart Interactive Chart >
SYNH Price/Volume Stats
Current price | $34.94 | 52-week high | $85.45 |
Prev. close | $34.52 | 52-week low | $22.89 |
Day low | $34.52 | Volume | 1,083,500 |
Day high | $35.25 | Avg. volume | 1,745,597 |
50-day MA | $36.53 | Dividend yield | N/A |
200-day MA | $48.77 | Market Cap | 3.61B |
Syneos Health, Inc. - (SYNH) Company Bio
Syneos Health, formerly INC Research Holdings, provide the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The company was founded in 2010 and is based in Raleigh, North Carolina.
Latest SYNH News From Around the Web
Below are the latest news stories about SYNEOS HEALTH INC that investors may wish to consider to help them evaluate SYNH as an investment opportunity.
Syneos Health (SYNH) Partners With KX for Data-Driven InsightsSyneos Health's (SYNH) partnership with KX is likely to accelerate clinical trial execution using AI-enabled solutions. |
Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset DevelopmentCollaboration Will Leverage Data Analytics and AI to Accelerate Clinical Trial ExecutionMORRISVILLE, N.C., March 22, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with KX, maker of kdb, the world’s fastest time series database and analytics engine. The partnership will deliver data-driven predictive analytics, Artificial Intelligence (AI) and Machine Learning (ML) capabilities to |
Syneos Health's (SYNH) New Microsoft Deal to Expand AI UsageWith the multi-year deal, Syneos Health (SYNH) aims to deliver technology and data solutions with Microsoft. |
Syneos Health inks deal with Microsoft to further use AI |
Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial ContinuumCollaboration Leverages AI-ready Technology to Speed Asset Development and Optimize PerformanceMORRISVILLE, N.C., March 20, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic multi-year agreement with Microsoft. Utilizing Microsoft Azure services, Syneos Health has developed an advanced analytics platform that enables agile deployment of machine learning (ML) supporting the analysis, design and e |
SYNH Price Returns
1-mo | -7.74% |
3-mo | -1.27% |
6-mo | -26.38% |
1-year | -56.13% |
3-year | -16.01% |
5-year | -1.58% |
YTD | -4.74% |
2022 | -64.28% |
2021 | 50.71% |
2020 | 14.55% |
2019 | 51.14% |
2018 | -9.75% |
Continue Researching SYNH
Want to see what other sources are saying about Syneos Health Inc's financials and stock price? Try the links below:Syneos Health Inc (SYNH) Stock Price | Nasdaq
Syneos Health Inc (SYNH) Stock Quote, History and News - Yahoo Finance
Syneos Health Inc (SYNH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...